Role of von Willebrand factor for the onset of arterial thrombosis

Clinical Laboratory

Volumn 47, Issue 7-8, 2001, Pages 327-334

  Goto, S ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arterial thrombosis; Endothelial cell; Platelets; Shear stress; Von Willebrand factor

Indexed keywords

ANTICOAGULANT AGENT; PLASMA PROTEIN; POLYMER; VON WILLEBRAND FACTOR;

ARTERY THROMBOSIS; BLEEDING; CHEMICAL STRUCTURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; INHIBITION KINETICS; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; SHEAR STRESS; THROMBOCYTE; THROMBOGENICITY; THROMBOSIS; VASCULAR ENDOTHELIUM;

ARTERIAL OCCLUSIVE DISEASES; BLOOD PLATELETS; HEMORHEOLOGY; HUMANS; STRESS, MECHANICAL; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 0034922076     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Amino acid sequence of human von Willebrand factor
2. von Willebrand factor
3. Multimeric composition of endothelial cell-derived von Willebrand factor
4. Endothelial cell-derived high molecular weight von Willebrand factor is converted into the plasma multimer pattern by granulocyte protease
5. Involvement of large plasma von Willebrand factor (VWF) multimers and unusually large VWF forms derived from endothelial cells in shear stress-induced platelet aggregation
6. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis
7. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion
8. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
9. Mechanism of platelet thrombus formation under flow
10. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments
11. Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by amino acid residues adjacent to the sequence Arg1744-Gly1745-Asp1746
12. Von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib
13. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites
14. Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli
15. Analysis of structure-function relationships in the platelet membrane glycoprotein Ib-binding domain of von Willebrand's factor by expression of deletion mutants
16. Studies on anti-von Willebrand factor (VWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced VWF binding to platelet glycoprotein Ib
17. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelet
18. Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibα under flow
19. Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibα
20. Abciximab not RGD peptide inhibits von Willebrand factor-dependent platelet activation under shear
21. The pathogenesis of coronary artery disease and the acute coronary syndromes (1)
22. The pathogenesis of coronary artery disease and the acute coronary syndromes (2)
23. Unstable angina pectoris
24. von Willebrand factor-dependent shear-induced platelet aggregation. Basic mechanism and clinical implications
25. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress
26. Platelets and shear stress
27. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor
28. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium
29. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor
30. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow
31. Von Willebrand factor biosynthesis and partitioning between constitutive and regulated pathways of secretion after thrombin stimulation
32. Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine
33. Fibrin induces release of von Willebrand factor from endothelial cells
34. Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by fibrin beta chain
35. Inducible secretion of large, biologically potent von Willebrand factor multimers
36. Epinephrine induces von Willebrand factor release from cultured endothelial cells: Involvement of cyclic AMP-dependent signalling in exocytosis
37. Expression of von Willebrand factor in porcine vessels: Heterogeneity at the level of von Willebrand factor mRNA
38. Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree
39. Von Willebrand factor is an acute phase reactant in man
40. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon
41. Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon
42. Endothelial dysfunction precedes development of microalbuminuria in IDDM
43. Role of von Willebrand factor in atherogenesis
44. Comparative behaviour of the components of the factor VIII complex in acute myocardial infarction
45. Plasma concentration of von Willebrand factor in acute myocardial infarction
46. Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics
47. Arterial thrombosis in heart failure
48. Von Willebrand factor abnormality in primary pulmonary hypertension
49. Differential regulation by cytokines of constitutive and regulated secretion of von Willebrand factor from endothelial cells
50. von Willebrand Factor. A marker of endothelial damage?
51. Fluid shear stress modulates von Willebrand factor release from human vascular endothelium
52. Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
53. Prospective study of hemostatic factors and incidence of coronary heart disease: The atherosclerosis risk in communities (ARIC) Study
54. Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries
55. Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor
56. Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs
57. Specific inhibiting characteristics of ligusrazine, active ingredient of chinese herbal medicine 'Chuanxiong', on von Willebrand factor dependent platelet thrombus formation
58. An anti-VWF monoclonal antibody, AJvW-2, inhibits enhanced platelet aggregation induced by high shear stress in platelet rich plasma from patients with acute coronary syndromes